Henan Cancer Hospital: Carcinoma, Squamous Cell trials

The registry lists 10 Carcinoma, Squamous Cell studies with Henan Cancer Hospital as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 2 5Phase 3 3No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Immunochemotherapy for Resectable Esophageal Cancer: A Target Trial Emulation StudyNot yet recruitingNCT07778056
• Carrilizumab Combined With White Purple for Squamous Cell Carcinoma of SkinRecruitingNCT05886140Not applicable
• Adjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT05495152Phase 3
• Camrelizumab Combined With Cisplatin in the Treatment of Advanced Cutaneous Squamous Cell CarcinomaRecruitingNCT05490485Phase 2
• Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)RecruitingNCT04138212Phase 3
• Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell CarcinomaActive, not recruitingNCT06888531Phase 2
• Anrotenib Plus Toripalimab Versus Toripalimab in Patients With Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT04229849Phase 2
• Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）.Status unknownNCT04063683Phase 2
• A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell CarcinomaStatus unknownNCT03424291Phase 2
• Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell CarcinomaCompletedNCT02395705Phase 3